Director, Structural Heart Imaging & Valve clinic, Texas Heart Institute, BSLMC.#WhyCMR, #YesCCT, #Echofirst |Associate Professor, Baylor College of Medicine.
Just published from our group @BCMAdvStrlHeart@Texas_Heart@BCM_CVRI LVAD recipients with elevated preoperative PVR, those with mod/severe MR had better overall survival and higher transplant rates than those with mild/no MR. @CBallantyneMD@ajith1230
We are excited to announce AGENT™ Drug-Coated Balloon is now FDA approved! AGENT is the first and only coronary drug-coated balloon in the U.S. and introduces a new treatment option for patients with in-stent restenosis. https://t.co/LNeqdi0y9b
#ICE vs #TEE for watchman implantation #NCDR data
🧊 39K patients at ~ 700 sites
🧊 infrequent ICE use only 5%
🧊82% of operators had performed <10 ICE-guided procedures
🧊 similar procedure time ( 82 minutes with ICE compared to 78 minutes with TEE)
🧊 no GA with ICE patients
🧊 similar success ( caution- self reported registry data)
🧊 higher pericardial effusion rates requiring intervention with ICE at 45 days- learning curve but poor ICE uptake nationally
https://t.co/Sp30Gm980D
#Echofirst #ACCimaging #CVimaging
@OKhaliqueMD@JoaoLCavalcante@iamritu@mswami001@kadiyala2000@onco_cardiology@AChoiHeart
PA Catheter Use and Mortality in the CICU. PAC use was associated with higher survival in cardiac patients with shock presenting to CICUs. Randomized trials needed to guide appropriate use of PACs in ICUs https://t.co/Eur6kBbEGy @JACCJournals#JACCHF
.@CBallantyneMD weighs in on a recent trial that found levels of omega-3 fatty acids aren't linked to an elevated risk for atrial fibrillation. https://t.co/QJk4w9vzWt #atrialfibrillation